Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Citi
Fish and Richardson
Medtronic
Colorcon
Federal Trade Commission
Argus Health
Mallinckrodt
Farmers Insurance
Express Scripts

Generated: October 16, 2017

DrugPatentWatch Database Preview

DIPHEN Drug Profile

« Back to Dashboard

What is the patent landscape for Diphen, and when can generic versions of Diphen launch?

Diphen is a drug marketed by Morton Grove, Usl Pharma, Whiteworth Town Plsn, Elkins Sinn, Pioneer Pharms, Mutual Pharm, Impax Labs, Cumberland Swan, Pharm Assoc, Halsey, Hi Tech Pharma, West-ward Pharms Int, Alra, Kv Pharm, Bel Mar, Heather, Pvt Form, Watson Labs, Vangard, Sandoz, Nexgen Pharma Inc, Roxane, Lederle, Purepac Pharm, Barr, Lannett, Superpharm, Hospira, Cenci, Newtron Pharms, Perrigo, Ivax Sub Teva Pharms, App Pharms, Lyphomed, Hikma Intl Pharms, Watson Labs Teva, Teva, Bundy, Anabolic, LNK, Wyeth Ayerst, Naska, Eurohlth Intl Sarl, Mk Labs, Sun Pharm Inds, Valeant Pharm Intl, Alpharma Us Pharms, Mylan Institutional, Fresenius Kabi Usa, Abraxis Pharm, Intl Medication, Inwood Labs, Ani Pharms Inc, Parke Davis, Ascot, R And S Pharma, Par Pharm, Mylan, Hikma Pharms, Able, and Scherer Rp. and is included in ninety-eight NDAs.

The generic ingredient in DIPHEN is phenytoin sodium. There are nineteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.

Summary for Tradename: DIPHEN

US Patents:0
Applicants:61
NDAs:98
Bulk Api Vendors: see list46
Clinical Trials: see list1
Patent Applications: see list9,882
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DIPHEN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
DIPHENHYDRAMINE HYDROCHLORIDE
diphenhydramine hydrochloride
CAPSULE;ORAL085083-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Kv Pharm
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
atropine sulfate; diphenoxylate hydrochloride
TABLET;ORAL085659-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Newtron Pharms
DIPHENHYDRAMINE HYDROCHLORIDE
diphenhydramine hydrochloride
CAPSULE;ORAL086543-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Purepac Pharm
DIPHENHYDRAMINE HYDROCHLORIDE
diphenhydramine hydrochloride
ELIXIR;ORAL083237-001Jan 25, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE
diphenhydramine hydrochloride
INJECTABLE;INJECTION091526-001Mar 26, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
Perrigo
DIPHENHYDRAMINE HYDROCHLORIDE
diphenhydramine hydrochloride
CAPSULE;ORAL083061-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Scherer Rp
DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE
atropine sulfate; diphenoxylate hydrochloride
CAPSULE;ORAL086440-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
DIPHENHYDRAMINE HYDROCHLORIDE
diphenhydramine hydrochloride
INJECTABLE;INJECTION080873-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
DIPHENHYDRAMINE HYDROCHLORIDE
diphenhydramine hydrochloride
CAPSULE;ORAL080845-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
atropine sulfate; diphenoxylate hydrochloride
TABLET;ORAL085762-001Approved Prior to Jan 1, 1982AARXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Mallinckrodt
Fish and Richardson
Farmers Insurance
Federal Trade Commission
Accenture
Chinese Patent Office
AstraZeneca
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot